Skip to main content

Advertisement

Table 2 Comparison of selected parameters between the group of NAFLD patients and non-hepatopathic obese patients

From: Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease

Parameter NAFLD group (n = 31) Median (Q1-Q3) Non – hepatopathic obese (n = 12) Median (Q1-Q3) P
Age (years) 14 (11–16) 12 (10.5–14) ns
BMI (kg/m2) 28.1 (26.6–33.5) 26.2 (25.3–29.5) 0.035
Waist (cm) 98 (94–107) 87 (82–94) 0.004
ALT (IU/l) 64 (51–104) 18 (15–21) < 0.001
GGT (IU/l) 30 (22–45) 15.0 (13.0–18.5) < 0.001
Cholesterol (mg/dl) 181 (159–216) 162.5 (139.5–182.0) ns
HDL-cholesterol (mg/dl) 45 (40–51) 50.5 (41–55.5) ns
LDL – cholesterol (mg/dl) 105 (80–145) 89.5 (74.0–105.5) ns
Triglycerides (TG) (mg/dl) 140 (85–167) 87.5 (73.0–121.0) 0.037
Glucose (mg/dl) 93 (84–99) 91 (86–96) ns
Insulin (μIU/ml) 17.4 (13.8–21.0) 14.8 (10.3–17.7) ns
HOMA – IR 3.9 (2.8–4.8) 3.4 (2.3–3.8) ns
TILC (r.u) 172 (120–216) 29 (17–58) < 0.001